Scholars@Duke

Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?

Publication ,  Journal Article
Zafar, SY; Peppercorn, JM
Published in: J Clin Oncol
July 1, 2017
Published version (DOI) Link to item

Duke Scholars

Syed Yousuf Zafar
Author Syed Yousuf Zafar Medicine, Medical Oncology

Published In

J Clin Oncol

DOI

10.1200/JCO.2016.71.7280

EISSN

1527-7755

Publication Date

July 1, 2017

Volume

35

Issue

19

Start / End Page

2113 / 2116

Location

United States

Related Subject Headings

  • Quality Indicators, Health Care
  • Oncology & Carcinogenesis
  • Neoplasms
  • Medical Assistance
  • Insurance, Health
  • Humans
  • Healthcare Disparities
  • Health Services Accessibility
  • Health Expenditures
  • Drug Industry
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zafar, S. Y., & Peppercorn, J. M. (2017). Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care? J Clin Oncol, 35(19), 2113–2116. https://doi.org/10.1200/JCO.2016.71.7280
Zafar, S Yousuf, and Jeffrey M. Peppercorn. “Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?” J Clin Oncol 35, no. 19 (July 1, 2017): 2113–16. https://doi.org/10.1200/JCO.2016.71.7280.
Zafar, S. Yousuf, and Jeffrey M. Peppercorn. “Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?” J Clin Oncol, vol. 35, no. 19, July 2017, pp. 2113–16. Pubmed, doi:10.1200/JCO.2016.71.7280.
Zafar SY, Peppercorn JM. Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care? J Clin Oncol. 2017 Jul 1;35(19):2113–2116.

Published In

J Clin Oncol

DOI

10.1200/JCO.2016.71.7280

EISSN

1527-7755

Publication Date

July 1, 2017

Volume

35

Issue

19

Start / End Page

2113 / 2116

Location

United States

Related Subject Headings

  • Quality Indicators, Health Care
  • Oncology & Carcinogenesis
  • Neoplasms
  • Medical Assistance
  • Insurance, Health
  • Humans
  • Healthcare Disparities
  • Health Services Accessibility
  • Health Expenditures
  • Drug Industry